PressMay 21, 2026 GH Research to present new GH001 Phase 2b data in treatment-resistant depression at ASCP 2026
PressMay 11, 2026 Reunion to present full RECONNECT Phase 2 data for luvesilocin in postpartum depression
PressApril 24, 2026 FDA grants Compass rolling NDA review and a National Priority Voucher for COMP360
PressApril 23, 2026 Psyence doses first patient in Phase 2b psilocybin trial for cancer-related adjustment disorder
PressApril 20, 2026 Helus Pharma CEO Michael Cola steps down; co-founder Eric So returns as interim CEO
